These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32920378)

  • 1. Genetic testing and the phenotype of Polish patients with Unverricht-Lundborg disease (EPM1) - A cohort study.
    Bosak M; Sułek A; Łukasik M; Żak A; Słowik A; Lasek-Bal A
    Epilepsy Behav; 2020 Nov; 112():107439. PubMed ID: 32920378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severer phenotype in Unverricht-Lundborg disease (EPM1) patients compound heterozygous for the dodecamer repeat expansion and the c.202C>T mutation in the CSTB gene.
    Koskenkorva P; Hyppönen J; Aikiä M; Mervaala E; Kiviranta T; Eriksson K; Lehesjoki AE; Vanninen R; Kälviäinen R
    Neurodegener Dis; 2011; 8(6):515-22. PubMed ID: 21757863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroclinical presentation and genotype-phenotype relationships in patients with Unverricht-Lundborg disease carrying compound heterozygous CSTB point and indel mutations.
    Canafoglia L; Gennaro E; Capovilla G; Gobbi G; Boni A; Beccaria F; Viri M; Michelucci R; Agazzi P; Assereto S; Coviello DA; Di Stefano M; Rossi Sebastiano D; Franceschetti S; Zara F
    Epilepsia; 2012 Dec; 53(12):2120-7. PubMed ID: 23205931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refining the phenotype of Unverricht-Lundborg disease (EPM1): a population-wide Finnish study.
    Hyppönen J; Äikiä M; Joensuu T; Julkunen P; Danner N; Koskenkorva P; Vanninen R; Lehesjoki AE; Mervaala E; Kälviäinen R
    Neurology; 2015 Apr; 84(15):1529-36. PubMed ID: 25770194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the Genetic Profile of Two Siblings Affected by Unverricht-Lundborg Disease Using Patient-Derived hiPSCs.
    Lucchino V; Scaramuzzino L; Scalise S; Lo Conte M; Zannino C; Benedetto GL; Aguglia U; Ferlazzo E; Cuda G; Parrotta EI
    Cells; 2022 Nov; 11(21):. PubMed ID: 36359887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular characterization of Unverricht-Lundborg disease among Egyptian patients.
    Hosny H; El Tamawy M; Gouider R; Lesca G; Abdel Naseer M; Kishk N; Abdel-Hamid MS; Ashmawi A
    Epilepsy Res; 2021 Oct; 176():106746. PubMed ID: 34474241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unverricht-Lundborg disease.
    Crespel A; Ferlazzo E; Franceschetti S; Genton P; Gouider R; Kälviäinen R; Korja M; Lehtinen MK; Mervaala E; Simonato M; Vaarmann A
    Epileptic Disord; 2016 Sep; 18(S2):28-37. PubMed ID: 27582036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unverricht-Lundborg progressive myoclonus epilepsy in Oman.
    Santoshkumar B; Turnbull J; Minassian BA
    Pediatr Neurol; 2008 Apr; 38(4):252-5. PubMed ID: 18358403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A shared haplotype indicates a founder event in Unverricht-Lundborg disease patients from Serbia.
    Kecmanović M; Ristić AJ; Ercegovac M; Keckarević-Marković M; Keckarević D; Sokić D; Romac S
    Int J Neurosci; 2014 Feb; 124(2):102-9. PubMed ID: 23883076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel c132-134del mutation in Unverricht-Lundborg disease and the review of literature of heterozygous compound patients.
    Assenza G; Benvenga A; Gennaro E; Tombini M; Campana C; Assenza F; Di Pino G; Di Lazzaro V
    Epilepsia; 2017 Feb; 58(2):e31-e35. PubMed ID: 27888502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unverricht-Lundborg disease in a five-generation Arab family: instability of dodecamer repeats.
    Mazarib A; Xiong L; Neufeld MY; Birnbaum M; Korczyn AD; Pandolfo M; Berkovic SF
    Neurology; 2001 Sep; 57(6):1050-4. PubMed ID: 11571333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystatin B: mutation detection, alternative splicing and expression in progressive myclonus epilepsy of Unverricht-Lundborg type (EPM1) patients.
    Joensuu T; Kuronen M; Alakurtti K; Tegelberg S; Hakala P; Aalto A; Huopaniemi L; Aula N; Michellucci R; Eriksson K; Lehesjoki AE
    Eur J Hum Genet; 2007 Feb; 15(2):185-93. PubMed ID: 17003839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOunder effect in patients with Unverricht-Lundborg disease on reunion island.
    Moulard B; Darcel F; Mignard D; Jeanpierre M; Genton P; Cartault F; Yaouanq J; Roubertie A; Biraben A; Buresi C; Malafosse A
    Epilepsia; 2003 Oct; 44(10):1357-60. PubMed ID: 14510831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First Molecular Diagnosis of a Patient with Unverricht-Lundborg Disease in Korea.
    Kim KH; Song JS; Park CW; Ki CS; Heo K
    Yonsei Med J; 2018 Aug; 59(6):798-800. PubMed ID: 29978618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haplotype study of West European and North African Unverricht-Lundborg chromosomes: evidence for a few founder mutations.
    Moulard B; Genton P; Grid D; Jeanpierre M; Ouazzani R; Mrabet A; Morris M; LeGuern E; Dravet C; Mauguière F; Utermann B; Baldy-Moulinier M; Belaidi H; Bertran F; Biraben A; Ali Chérif A; Chkili T; Crespel A; Darcel F; Dulac O; Geny C; Humbert-Claude V; Kassiotis P; Buresi C; Malafosse A
    Hum Genet; 2002 Sep; 111(3):255-62. PubMed ID: 12215838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of human induced pluripotent stem cell lines (UNIMGi003-A and UNIMGi004-A) from two Italian siblings affected by Unverricht-Lundborg disease.
    Lucchino V; Scaramuzzino L; Scalise S; Grillone K; Lo Conte M; Esposito C; Aguglia U; Ferlazzo E; Perrotti N; Malatesta P; Parrotta EI; Cuda G
    Stem Cell Res; 2021 May; 53():102329. PubMed ID: 33865103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Juvenile myoclonic epilepsy phenotype in a family with Unverricht-Lundborg disease.
    Berrechid AG; Bendjebara M; Bouteiller D; Nasri A; Peuvion JN; Marie Y; Baulac S; Mrabet S; Ribierre T; Cazeneuve C; Imenkacem ; Leguern E; Gouider R
    Epileptic Disord; 2019 Aug; 21(4):359-365. PubMed ID: 31368437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA deamination enables direct PCR amplification of the cystatin B (CSTB) gene-associated dodecamer repeat expansion in myoclonus epilepsy type Unverricht-Lundborg.
    Weinhaeusel A; Morris MA; Antonarakis SE; Haas OA
    Hum Mutat; 2003 Nov; 22(5):404-8. PubMed ID: 14517952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative myoclonus causes locomotory disability in progressive myoclonus epilepsy type EPM1- Unverricht-Lundborg disease.
    Vogt H; Baisch T; Mueller-Pfeiffer C; Mothersill IW
    Epileptic Disord; 2023 Jun; 25(3):297-308. PubMed ID: 37536959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular background of EPM1-Unverricht-Lundborg disease.
    Joensuu T; Lehesjoki AE; Kopra O
    Epilepsia; 2008 Apr; 49(4):557-63. PubMed ID: 18028412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.